Nov. 20 - University Innovation Symposium
November 20, 2010 from 8:30 A.M. until 6:30 P.M.
American University, Washington College of Law, Room 603
4801 Massachusetts Ave., NW Washington, DC 20016
PIJIP and Universities Allied for Essential Medicines will cohost this symposium for NGO representatives, university professors and administrators, and policy makers to focus on strategies to increase research on neglected diseases and innovative policies for universities to contribute most effectively to the medicines innovation system. Topics will include intellectual property protection, licensing, and alternate models of funding.
Click here to register - select the drop down and scroll to "Nov. 20 Workshop on Neglected Diseases"
Agenda (updated October 5, 2010)
Universities are increasingly integrated into the pharmaceutical innovation system. Institutions such as Yale and the University of British Columbia, for instance, now have their own high through-put screening facilities, traditionally controlled only by industry, which allow them to do rapid tests of thousands of molecules in their compound libraries to screen for potential new drug targets. Yale has taken this a step further by purchasing a facility from pharmaceutical company Bayer in order to quicken the pace and scope of its biomedical research capabilities.
Universities are also engaging increasingly with product development partnerships product development partnerships (PDPs) such as DNDi to aid them in finding cures for diseases of the poor. Combined with the trend toward open access publishing standards for academic papers at many schools, universities are well placed to accelerate the ability of researchers to find life-saving discoveries.
In order to address and further explore these possibilities, UAEM is holding a symposium on the role of universities as non-profit institutions in the medicine innovation system, particularly related to their role in finding cures for neglected diseases as well as open-source research methods.
The meeting will bring together product development partnerships (PDPs), university administrators, researchers, industry actors, technology transfer officials, funding institutions and students to explore the role of universities in the broader innovation system and directions for university policy to best improve both innovation and access to medicines.
We hope you can join us as we gather in Washington, D.C., on November 20, 2010 from 8:30 A.M to 6:30 P.M.
Please continue to check back at this site for the most updated information regarding the conference. We look forward to seeing you in November.
The symposium is made possible by the kind support of the Perls Foundation
Confirmed Speakers and Participants include
Rohit Malpani, Oxfam
Bhaven Sampat, Columbia University
Gloria Tavera, NIH Research Fellow, UAEM
Kishor Wasan, University of British Columbia
Rita Khanna, Aeras Global TB Vaccine Foudation
Sandeep Kishore, Weill-Cornell Medical College, UAEM
James Love, Director, Knowledge Ecology International
Pamela Small, University of Tennessee
Zakir Thomas, Open Source Drug Discovery Network, India
Heather Joseph, Executive Director, SPARC
Rebecca Goulding, Open Health Initiative
Matt Todd, The Synaptic Leap, Australia
Dr. Tom Wellems, National Institute of Allergy and Infectious Disease
Rachel Kiddell-Monroe, Universities Allied for Essential Medicines
Image of Pills (cc) Fillmore Photography.